loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X

Annual Sales of Omalizumab reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Xolair (2)

URL Supplier Web Content
Xolair
Respiratory Disorders
USD
613
777
26.80%
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xolair
Immunology
CHF
1,969
1,912
2,028
1,969
59
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xolair
Respiratory Disorders
USD
1,251
1,173
1,251
1,173
78
7
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xolair
Immunology
CHF
1,904
1,969
2,121
2,194
-72
-3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xolair
Respiratory Disorders
USD
1,428
1,251
1,428
1,251
177
14
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xolair
Immunology
CHF
1,942
1,904
2,090
2,018
72
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xolair
Immunology
USD
1,365
1,428
1,365
1,428
-63
-4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xolair
Immunology
CHF
2,208
1,942
2,414
2,090
324
15
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xolair
Immunology
USD
1,463
1,365
1,463
1,365
98
7
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xolair
Immunology
CHF
2,176
2,208
2,525
2,414
111
-1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY